Columbus Circle Investors’s Boston Scientific BSX Stock Holding History

Columbus Circle Investors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-899,917	Closed	-$34.5M	–	161
2019 Q1	$34.5M	Sell	899,917 -138,176	-13%	-$5.28M	0.88%	48
2018 Q4	$36.7M	Buy	1,038,093 +123,452	+13%	+$4.48M	1.04%	33
2018 Q3	$35.2M	Buy	914,641 +170,745	+23%	+$5.96M	0.7%	49
2018 Q2	$24.3M	Buy	+743,896	New	+$22.4M	0.5%	82
2017 Q1	–	Sell	-65,272	Closed	-$1.41M	–	277
2016 Q4	$1.41M	Sell	65,272 -3,961,445	-98%	-$86.4M	0.02%	223
2016 Q3	$95.8M	Buy	4,026,717 +1,248,877	+45%	+$29.8M	1.03%	29
2016 Q2	$64.9M	Buy	+2,777,840	New	+$60.1M	0.65%	53
2014 Q3	–	Sell	-9,706,535	Closed	-$124M	–	269
2014 Q2	$124M	Sell	9,706,535 -2,505,588	-21%	-$32.6M	0.85%	38
2014 Q1	$165M	Buy	12,212,123 +4,669,322	+62%	+$61.3M	1.1%	29
2013 Q4	$90.7M	Buy	7,542,801 +56,933	+0.8%	+$673K	0.62%	53
2013 Q3	$87.9M	Buy	+7,485,868	New	+$81M	0.62%	53

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Columbus Circle Investors's BSX Position: Q2 2019 in Review

Columbus Circle Investors sold out of Boston Scientific (BSX) in Q2 2019, closing a stake of 899,917 shares — an estimated $34.5M sold.

Columbus Circle Investors first reported a position in BSX in Q3 2013 and held it in 11 quarters. The position peaked at $165M in Q1 2014. 757 funds tracked by Wall St. Rank hold BSX as of Q2 2019.

Columbus Circle Investors reported no remaining Boston Scientific position as of Q2 2019 after selling out during the quarter.
Columbus Circle Investors sold 899,917 Boston Scientific shares in Q2 2019, an estimated $34.5M.
Columbus Circle Investors first reported a position in Boston Scientific in Q3 2013 and held it in 11 quarters.
Columbus Circle Investors's Boston Scientific position peaked at $165M in Q1 2014.
757 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2019.

Based on Columbus Circle Investors's 13F filing for Q2 2019, filed 2 Aug 2019.